CAS: 1044511-01-4 - Benralizumab
Fórmula:Unspecified
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Benralizumab REF: TM-T10497CAS: 1044511-01-4 | 98% | 500,00 €~3.211,00 € | Mar 07 May 24 |
 | Benralizumab REF: 3D-CLA1249CAS: 1044511-01-4 | - - - | A consultar | Vie 17 May 24 |
Benralizumab
CAS:1044511-01-4
Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα). It enhances antibody-dependent …
Pureza:
98%
Forma y color:
Solid
Peso molecular:
N/A
Ref: TM-T10497
| 1mg | 500,00 € | |
| 2mg | 806,00 € | |
| 5mg | 1.383,00 € | |
| 10mg | 2.153,00 € | |
| 25mg | 3.211,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
Benralizumab
CAS:1044511-01-4
Please enquire for more information about Benralizumab including the price, delivery time and more detailed …
Ref: 3D-CLA1249
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
